SeaStar Medical (ICU) announced that Michael Messinger has joined SeaStar Medical as CFO. He currently serves as a member of the board of directors of Filament Health Corp. (FLHLF) and a strategic consultant to various biotechnology companies.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICU:
- SeaStar Medical Reports Q3 2025 Financial Progress
- ICU Upcoming Earnings Report: What to Expect?
- Seastar Medical’s QUELIMMUNE Study: A Potential Game Changer for Pediatric AKI Treatment
- Seastar Medical’s Pivotal Study on Acute Kidney Injury: A Potential Game-Changer?
- Seastar Medical’s Innovative Approach to Treating Severe Heart Failure: A Study Update